Platelet Rich Plasma (PRP) Treatment: A Viable Treatment for Myocardial Ischemic Reperfusion Injury
Journal of Cardiovascular Medicine and Cardiology · 02.04.2026 · 013-022
DOI: 10.17352/2455-2976.000238 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiovascular Medicine and Cardiology, online erschienen am 02.04.2026. Verfasst von Barbara Hargrave und 1 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Myocardial infarction and several surgical and vascular procedures contribute to MIRI. Research has primarily focused on the restoration of blood flow to the ischemic tissue. However, an inherent response to restoring blood flow to heart tissue after ischemia is reperfusion injury generated in part by an increase in the production of reactive oxygen species (ROS). Platelet-rich plasma (PRP) is a promising treatment for supporting cardiomyocytes exposed to MIRI and oxidative stress. We assessed the effects of PRP in the presence or absence of the NOX- 2 or NOX-4 inhibitors using the rabbit Langendorf heart method of MIRI and in cardiac myoblast cells (H9c2) and Adipose Derived Stem Cells (ADSC) exposed to hypoxia. Left ventricular systolic (LVSP), diastolic (LVDP), and work function (LVWF) were analyzed in the Langendorff hearts. The ROS concentration, hypoxia-inducible factor 1-alpha activity, and channel formation were analyzed in cardiac myoblast cells, in vitro.
Zitieren
APA
Hargrave, B., & Lattanzio, F. (2026). Platelet Rich Plasma (PRP) Treatment: A Viable Treatment for Myocardial Ischemic Reperfusion Injury. Journal of Cardiovascular Medicine and Cardiology, 013-022. https://doi.org/10.17352/2455-2976.000238
Vancouver
Hargrave B, Lattanzio F. Platelet Rich Plasma (PRP) Treatment: A Viable Treatment for Myocardial Ischemic Reperfusion Injury. Journal of Cardiovascular Medicine and Cardiology. 2026:013-022. doi:10.17352/2455-2976.000238
BibTeX
@article{Hargrave2026,
author = {Hargrave, Barbara and Lattanzio, Frank},
title = {Platelet Rich Plasma (PRP) Treatment: A Viable Treatment for Myocardial Ischemic Reperfusion Injury},
journal = {Journal of Cardiovascular Medicine and Cardiology},
year = {2026},
pages = {013--022},
doi = {10.17352/2455-2976.000238}
}
EUVIMED